Prestige Biopharma Announces Positive Topline Results from Comparative SAMSON-II Study for HD204, a Potential Biosimilar to Avastin (bevacizumab) - Thailand PR News - [Banking](https://thailandbusinessnews.net/category/banking/) - [Companies](https://thailandbusinessnews.net/category/companies/) - [Economy](https://thailandbusinessnews.net/category/economy/) - [Press Releases](https://thailandbusinessnews.net/category/press-release/) - [PR Newswire](https://thailandbusinessnews.net/pr-newswire-updates/) - [Tech](https://thailandbusinessnews.net/category/tech/) - [Tourism](https://thailandbusinessnews.net/category/tourism/) - [Press Release](https://thailandbusinessnews.net/category/press-release/) # Prestige Biopharma Announces Positive Topline Results from Comparative SAMSON-II Study for HD204, a Potential Biosimilar to Avastin (bevacizumab) ##### Up next ![Huawei Releases the NG WAN White Paper to Fully Upgrade IP Bearer Networks and Drive New Growth for Carriers](https://i0.wp.com/mma.prnasia.com/media2/2940806/image1.jpg?resize=200%2C110&ssl=1 "Huawei Releases the NG WAN White Paper to Fully Upgrade IP Bearer Networks and Drive New Growth for Carriers") [](https://thailandbusinessnews.net/press-release/huawei-releases-the-ng-wan-white-paper-to-fully-upgrade-ip-bearer-networks-and-drive-new-growth-for-carriers/) ###### [Huawei Releases the NG WAN White Paper to Fully Upgrade IP Bearer Networks and Drive New Growth for Carriers](https://thailandbusinessnews.net/press-release/huawei-releases-the-ng-wan-white-paper-to-fully-upgrade-ip-bearer-networks-and-drive-new-growth-for-carriers/) Published on 24 March 2026 ##### Author ##### [ CISION PRNewswire ](https://thailandbusinessnews.net/author/cision/) ##### Tags - [PRNewswire](https://thailandbusinessnews.net/tag/prnewswire/) Primary endpoint of Overall Response Rate at Week 18 met, demonstrating clinical equivalence in patients with advanced non-squamous non-small cell lung cancer SINGAPORE, March 24, 2026 /PRNewswire/ — Prestige Biopharma today announced positive topline results from its Phase 3 SAMSON-II study evaluating HD204, a proposed biosimilar to Avastin® (bevacizumab) in adult patients with advanced non-squamous non-small cell lung cancer (NSCLC). SAMSON-II is a randomized, double blind, parallel group, multicenter Phase 3 study conducted in 625 patients across 91 centers in 15 countries. Patients were randomized in a 1:1 ratio to receive HD204 or Avastin in combination with standard chemotherapy. The study met its primary endpoint of overall response rate (ORR) at Week 18, demonstrating clinical equivalence between HD204 and Avastin within the prespecified equivalence margin. ORR at Week 18 was 48.7% in the HD204 arm compared with 46.5% in the Avastin arm. The risk ratio was 1.047 (95% confidence interval \[CI\]: 0.86–1.27), and the risk difference was 0.022 (95% CI: −0.07–0.11), with both estimates falling within the predefined equivalence range. Secondary efficacy endpoints were supportive of the primary analysis. Comparable overall response rates were observed at Week 12, and time-to-event outcomes demonstrated similar progression-free survival (PFS) and overall survival (OS) between treatment groups, with no statistically significant differences identified. HD204 demonstrated a safety and tolerability profile consistent with the established safety experience of bevacizumab. Treatment-related adverse events were reported in 33.9% of patients receiving HD204 and 34.4% of patients receiving Avastin, while treatment-related serious adverse events occurred in 5.2% and 8.3% of patients, respectively. No new or unexpected safety signals were identified. The clinical outcomes observed in SAMSON-II were consistent with the high degree of analytical and clinical pharmacokinetic (PK) similarity demonstrated between HD204 and Avastin. SAMSON-II results strengthen the collective global experience showing that sensitive analytical characterization and comparative clinical PK studies can reliably predict equivalent clinical performance in biosimilar development. Prestige Biopharma is advancing regulatory pathways for HD204 based on the strong analytical and clinical PK programs, while sharing the SAMSON-II findings to further contribute to the global scientific experience in biosimilar evaluation. "These results illustrate the increasing precision with which biosimilarity can be established through advanced analytical and clinical PK studies," said Dr. Lisa Park, Chief Executive Officer of Prestige Biopharma. "Our experience with HD204 supports the view that well-designed development programs can reliably anticipate clinical performance, enabling more focused and efficient biosimilar development. By reducing unnecessary clinical burden, such advances can accelerate patient access to high-quality biologic medicines and support more sustainable healthcare systems worldwide." [Source link ](http://www.prnasia.com/story/archive/4917543_AE17543_0?rand=89749) ``` This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network ``` ##### You May Also Like [](https://thailandbusinessnews.net/press-release/arbele-wins-top-prize-at-bcics-4th-annual-biomedical-pitch-competition/) ## Arbele Wins Top Prize at BCIC's 4th Annual Biomedical Pitch Competition BOSTON, July 2, 2025 /PRNewswire/ — Arbele Limited, a Hong Kong-based biotech… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - July 2, 2025 [](https://thailandbusinessnews.net/press-release/futu-unveils-major-ai-upgrade-making-professional-agentic-investing-accessible-to-all-seize-the-next-rally-with-futu-ai/) ![Futu Unveils Major AI Upgrade, Making Professional Agentic Investing Accessible to All, Seize the Next Rally with FUTU AI](https://i0.wp.com/mma.prnasia.com/media2/3006281/image1.jpg?resize=260%2C140&ssl=1 "Futu Unveils Major AI Upgrade, Making Professional Agentic Investing Accessible to All, Seize the Next Rally with FUTU AI") - [Press Release](https://thailandbusinessnews.net/category/press-release/) ## Futu Unveils Major AI Upgrade, Making Professional Agentic Investing Accessible to All, Seize the Next Rally with FUTU AI HONG KONG, July 16, 2026 /PRNewswire/ — Futu Securities International (Hong Kong)… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - July 16, 2026 [](https://thailandbusinessnews.net/press-release/2025-acr-abstract-released-exciting-data-from-telitacicepts-phase-iii-clinical-study-in-sjogrens-syndrome-in-china/) ## 2025 ACR Abstract Released! Exciting Data from Telitacicept's Phase III Clinical Study in Sjögren's Syndrome in China In the results of China Phase III clinical trial announced at the… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - October 14, 2025 ##### Most Read - [![Priority Pass to accelerate travel innovation, backed by the Collinson Group's £500 million growth programme](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/priority-pass-to-accelerate-travel-innovation-backed-by-the-collinson-groups-500-million-growth-programme-2/ "Priority Pass to accelerate travel innovation, backed by the Collinson Group's £500 million growth programme") [Priority Pass to accelerate travel innovation, backed by the Collinson Group's £500 million growth programme](https://thailandbusinessnews.net/press-release/priority-pass-to-accelerate-travel-innovation-backed-by-the-collinson-groups-500-million-growth-programme-2/ "Priority Pass to accelerate travel innovation, backed by the Collinson Group's £500 million growth programme") - [![Modern Meadow and Bellroy Partner on Carry Products Made of Next-Generation Material](https://i0.wp.com/r2.thailandbusinessnews.net/2025/04/MODERN_MEADOW_LOGO_BLACK_PNG_Logo.jpg?fit=597%2C138&ssl=1&resize=40%2C40)](https://thailandbusinessnews.net/press-release/modern-meadow-and-bellroy-partner-on-carry-products-made-of-next-generation-material/ "Modern Meadow and Bellroy Partner on Carry Products Made of Next-Generation Material") [Modern Meadow and Bellroy Partner on Carry Products Made of Next-Generation Material](https://thailandbusinessnews.net/press-release/modern-meadow-and-bellroy-partner-on-carry-products-made-of-next-generation-material/ "Modern Meadow and Bellroy Partner on Carry Products Made of Next-Generation Material") - [![IMG Completes Acquisition of World Nomads, Expanding Global Travel Insurance Distribution](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/img-completes-acquisition-of-world-nomads-expanding-global-travel-insurance-distribution/ "IMG Completes Acquisition of World Nomads, Expanding Global Travel Insurance Distribution") [IMG Completes Acquisition of World Nomads, Expanding Global Travel Insurance Distribution](https://thailandbusinessnews.net/press-release/img-completes-acquisition-of-world-nomads-expanding-global-travel-insurance-distribution/ "IMG Completes Acquisition of World Nomads, Expanding Global Travel Insurance Distribution") - [![DORCO Wins 2026 Red Dot Award for Renewed Corporate Identity](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/dorco-wins-2026-red-dot-award-for-renewed-corporate-identity/ "DORCO Wins 2026 Red Dot Award for Renewed Corporate Identity") [DORCO Wins 2026 Red Dot Award for Renewed Corporate Identity](https://thailandbusinessnews.net/press-release/dorco-wins-2026-red-dot-award-for-renewed-corporate-identity/ "DORCO Wins 2026 Red Dot Award for Renewed Corporate Identity") - [![Tamarind Health launches Rare Cancer Centre to make specialist expertise easier to access](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/tamarind-health-launches-rare-cancer-centre-to-make-specialist-expertise-easier-to-access/ "Tamarind Health launches Rare Cancer Centre to make specialist expertise easier to access") [Tamarind Health launches Rare Cancer Centre to make specialist expertise easier to access](https://thailandbusinessnews.net/press-release/tamarind-health-launches-rare-cancer-centre-to-make-specialist-expertise-easier-to-access/ "Tamarind Health launches Rare Cancer Centre to make specialist expertise easier to access") - [![MemoMind One Rolls Out New Features and Prepares for a New Stage of Developer Access](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/memomind-one-rolls-out-new-features-and-prepares-for-a-new-stage-of-developer-access/ "MemoMind One Rolls Out New Features and Prepares for a New Stage of Developer Access") [MemoMind One Rolls Out New Features and Prepares for a New Stage of Developer Access](https://thailandbusinessnews.net/press-release/memomind-one-rolls-out-new-features-and-prepares-for-a-new-stage-of-developer-access/ "MemoMind One Rolls Out New Features and Prepares for a New Stage of Developer Access") ##### Subscribe via Email Enter your email address to subscribe and receive notifications of new posts by email. Email Address Subscribe [](https://thailandbusinessnews.net/press-release/dbs-gathers-global-leaders-at-inaugural-asia-future-forward-conference-as-ai-rewrites-the-world/) ## DBS Gathers Global Leaders At Inaugural Asia Future Forward Conference As AI Rewrites The World Shou Chew, Lip-Bu Tan, Hock Tan and Jenny Johnson among influential figures… [](https://thailandbusinessnews.net/press-release/midea-showcases-breakthrough-cooling-technologies-for-high-density-ai-data-centers-at-data-center-world-asia-2026/) ![Midea Showcases Breakthrough Cooling Technologies for High-Density AI Data Centers at Data Center World Asia 2026](https://i0.wp.com/mmx.prnasia.com/media/MS1999346/20260929231123EDT_image_1.jpg?resize=260%2C140&ssl=1 "Midea Showcases Breakthrough Cooling Technologies for High-Density AI Data Centers at Data Center World Asia 2026") ## Midea Showcases Breakthrough Cooling Technologies for High-Density AI Data Centers at Data Center World Asia 2026 SINGAPORE, Oct. 2, 2026 /PRNewswire/ — The Asia Data Centre World 2026… [](https://thailandbusinessnews.net/press-release/registration-opens-for-the-2026-eye-level-math-olympiad/) ![Registration Opens for the 2026 Eye Level Math Olympiad](https://i0.wp.com/mmx.prnasia.com/media/MS2000596/20261001022140EDT_image_1.jpg?resize=260%2C140&ssl=1 "Registration Opens for the 2026 Eye Level Math Olympiad") ## Registration Opens for the 2026 Eye Level Math Olympiad SEOUL, South Korea, Oct. 2, 2026 /PRNewswire/ — Eye Level has opened… [](https://thailandbusinessnews.net/press-release/curaleaf-international-secures-australian-first-with-tga-registered-liquid-medical-cannabis-inhalation-device-and-extends-availability-to-new-zealand/) ![Curaleaf International Secures Australian First with TGA Registered Liquid Medical Cannabis Inhalation Device and Extends Availability to New Zealand](https://i0.wp.com/mmx.prnasia.com/media/MS1612515/Curaleaf-International-Logo.jpg?resize=260%2C140&ssl=1 "Curaleaf International Secures Australian First with TGA Registered Liquid Medical Cannabis Inhalation Device and Extends Availability to New Zealand") ## Curaleaf International Secures Australian First with TGA Registered Liquid Medical Cannabis Inhalation Device and Extends Availability to New Zealand LONDON, Oct. 2, 2026 /PRNewswire/ — Curaleaf International, part of Curaleaf…